Pyrogen Testing Market worth $823.14 Million by 2019

The report “Pyrogen Testing Market by Product (Instruments, Services, Kits & Reagents), by Test (In Vitro, LAL, Rabbit Test), by Application (Pharmaceutical & Biotechnology Companies, Medical Devices, Other Applications) - Global Forecast to 2019”, report provides a detailed overview of the major drivers, restraints, challenges, opportunities, Trends, current market trends, and strategies impacting the global pyrogen testing market along with the estimates and forecasts of the revenue and market share analysis.

Browse 76 market data tables and 98 figures spread through 175 pages and in-depth TOC on “Pyrogen Testing Market"
Early buyers will receive 10% customization on this report.

The global pyrogen testing market was valued at $462.38 million in 2014. This market is expected to grow at a CAGR of 12.23% to reach $823.14 million in 2019.

The increasing number of new biologics products launched will be one of the most important growth drivers for this market in the forecast period (2014-2019). The number of new pharmaceutical products launched annually witnessed a strong upward trend between 2003 and 2013. The number of new products launched in 2013 was 56 as compared to 29 in 2003. The biologics pipeline has increased by 155%, from 355 treatments in 2001 to 907 in 2012.

Read More | Get the Sample Pages@

A strong pharmaceutical product pipeline will aid the growth of the pharmaceutical and biotechnology industries, which is an important end user of pyrogen testing products. According to the Ernst & Young’s ‘Global Biotechnology Report 2013’, companies in biotechnology centers in the U.S., Europe, Canada, and Australia achieved revenues of about $90 billion in 2012. This was an 8% increase over the revenues in 2011. According to OECD estimates, in 2011, the total number of biotechnology companies in the U.S. was 7,970, followed by Spain (3,025 biotechnology companies), and France (1,481 biotechnology companies). Owing to the rise in the number of biotechnology companies, biopharmaceutical production has increased globally.

The global pyrogen testing market is segmented on the basis of applications, products, tests, and geographies. By application, the market is divided into pharmaceuticals and biologicals, medical devices, and other applications such as water purification, food and beverages, cosmetics, and plastics and glass products. Of these, the pharmaceuticals and biologicals application segment accounted for the largest share of the global pyrogen testing market in 2014. The product segments included in this report are instruments, kits and reagents, and services. By test, the market is segmented into in vitro pyrogen test, LAL test, and rabbit test. The geographic segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW). The Asian segment is further divided into China, India, Japan, and the Rest of Asia. Europe is divided into France, Germany, Italy, Spain, the U.K., and the Rest of Europe. North America includes Canada and the U.S. The RoW encompasses Africa; Pacific and Oceania; and South America, Central America, and the Caribbean.

Get the Customized Information@

Major players in the pyrogen testing market include Associates of Cape Cod, Inc. (U.S.), Charles River Laboratories International, Inc. (U.S.), Ellab A/S (Denmark), GenScript (U.S.), Hyglos GmbH (Germany), Lonza Group (Switzerland), Merck & Co., Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Wako Chemicals USA, Inc. (U.S.).

Browse Related Reports:
In-Vitro Toxicology Testing Market
by Industry (Diagnostic, Pharmaceutical, Cosmetics, Chemical), Technology (Cell Culture, HTS, Omics), Applications (Systemic, Dermal, Ocular), Method (Cellular Assay, Ex vivo, In Silico) - Global Forecast to 2018.

Microbiology Testing/Clinical Microbiology Market by Product (Instrument, Analyzer, Incubator, Kit, Microscope, Molecular Diagnostics), Clinical Application (Periodontal Disease, Respiratory Diseases, STD, UTI) & by Industry - Global Forecast to 2019.

About MarketsandMarkets:
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Subscribe Reports from Healthcare Domain @

Mr. Rohan

Unit No. 802, 8th Floor,
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune – 411013,
Maharashtra, India.
Tel: +1-888-6006-441.
Visit MarketsandMarkets Blog @
Connect with us on LinkedIn @